TABLE OF CONTENTS
ABOUT THIS
PROSPECTUS
This prospectus is part of
an automatic registration statement on Form S-3 that we filed with the Securities and Exchange Commission (the “SEC”)
utilizing a “shelf” registration process as a “well-known seasoned issuer” as defined in Rule 405 under
the Securities Act of 1933, as amended (the “Securities Act”). Under this shelf registration process, we or selling
securityholders may offer and sell shares of our common stock, preferred stock, various series of debt securities, warrants to
purchase any of such securities, purchase contracts, or guarantees, either individually or as units in combination with other
securities, in one or more offerings. There is no limit on the aggregate amount of the securities that we or selling securityholders
may offer pursuant to the registration statement of which this prospectus is a part. This prospectus provides you with a general
description of the securities we or selling securityholders may offer.
Each time we or selling securityholders
offer securities under this prospectus, we will provide a prospectus supplement that will contain more specific information about
the terms of that offering. We may also authorize one or more free writing prospectuses to be provided to you that may contain
material information relating to these offerings. The prospectus supplement and any related free writing prospectus that we may
authorize to be provided to you may also add, update or change any of the information contained in this prospectus or in the documents
that we have incorporated by reference into this prospectus. We urge you to read carefully this prospectus, any applicable prospectus
supplement and any free writing prospectuses we have authorized for use in connection with a specific offering, together with
the information incorporated herein by reference as described in the section entitled “Incorporation of Certain Information
by Reference,” before buying any of the securities being offered.
This prospectus may not
be used to consummate a sale of securities unless it is accompanied by a prospectus supplement.
You should rely only on the
information contained in, or incorporated by reference into, this prospectus and the applicable prospectus supplement, along with
the information contained in any free writing prospectuses we have authorized for use in connection with a specific offering.
We have not authorized anyone to provide you with different or additional information. This prospectus is an offer to sell only
the securities offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so.
The information appearing
in this prospectus, any applicable prospectus supplement and any related free writing prospectus is accurate only as of the date
on the front of the document and any information we have incorporated by reference is accurate only as of the date of the document
incorporated by reference, regardless of the time of delivery of this prospectus, the applicable prospectus supplement or any
related free writing prospectus, or any sale of a security. Our business, financial condition, results of operations and prospects
may have changed since those dates.
This prospectus contains summaries
of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete
information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred
to herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration statement of which
this prospectus is a part, and you may obtain copies of those documents as described in the section entitled “Where You
Can Find More Information.”
Unless the context indicates
otherwise, as used in this prospectus, the terms “Uber,” “we,” “us,” and “our”
refer to Uber Technologies, Inc., a Delaware corporation, and, where appropriate, our consolidated subsidiaries. “Uber”,
the Uber logo, and other trademarks or service marks of Uber appearing in this prospectus are the property of Uber. This prospectus
contains additional trade names, trademarks and service marks of others, which are the property of their respective owners. Solely
for convenience, trademarks and trade names referred to in this prospectus may appear without the ® or ™
symbols.
PROSPECTUS
SUMMARY
This summary highlights
selected information contained elsewhere in this prospectus or incorporated by reference in this prospectus, and does not contain
all of the information that you need to consider in making your investment decision. You should carefully read the entire prospectus,
the applicable prospectus supplement and any related free writing prospectus, including the risks of investing in our securities
discussed in the section entitled “Risk Factors” contained in the applicable prospectus supplement and any related
free writing prospectus, and under similar headings in the other documents that are incorporated by reference into this prospectus.
You should also carefully read the information incorporated by reference into this prospectus, including our financial statements,
and the exhibits to the registration statement of which this prospectus is a part.
Overview
We are a technology platform
that uses a massive network, leading technology, operational excellence, and product expertise to power movement from point A
to point B. We develop and operate proprietary technology applications supporting a variety of offerings on our platform (“platform(s)”
or “Platform(s)”). We connect consumers (“Rider(s)”) with independent providers of ride services (“Rides
Driver(s)”) for ridesharing services, and connect consumers (“Eater(s)”) with restaurants (“Restaurant(s)”)
and food delivery service providers (“Delivery People”) for meal preparation and delivery services. Riders and Eaters
are collectively referred to as “end-user(s)” or “consumer(s).” Rides Drivers and Delivery People are
collectively referred to as “Driver(s)”. We also connect consumers with public transportation networks, e-bikes, e-scooters,
and other personal mobility options. We use this same network, technology, operational excellence and product expertise to connect
shippers with carriers in the freight industry. We are also developing technologies that will provide autonomous driving vehicle
solutions to consumers, networks of vertical take-off and landing vehicles and new solutions to solve everyday problems.
Our technology is available
in 69 countries around the world, principally in the United States (“U.S.”) and Canada, Latin America, Europe, the
Middle East, Africa, and Asia (excluding China and Southeast Asia).
Corporate Information
We were founded in 2009 and incorporated
as Ubercab, Inc., a Delaware corporation, in July 2010. In February 2011, we changed our name to Uber Technologies, Inc. Our principal
executive offices are located at 1455 Market Street, 4th Floor, San Francisco, California 94103, and our telephone number is (415) 612-8582.
Our website address is www.uber.com. Information contained on or accessible through our website is not a part of this prospectus or the
registration statement of which it forms a part, and the inclusion of our website address in this prospectus is an inactive textual reference
only.
Description of Securities
We or selling securityholders
may offer shares of our common stock, preferred stock, various series of debt securities, warrants to purchase any of such securities,
purchase contracts or guarantees, either individually or as units in combination with other securities, from time to time under
this prospectus, together with the applicable prospectus supplement and any related free writing prospectus, at prices and on
terms to be determined by market conditions at the time of any offering. This prospectus provides you with a general description
of the securities we or selling securityholders may offer. Each time we or selling securityholders offer a type or series of securities
under this prospectus, we will provide a prospectus supplement that will describe the specific amounts, prices, and other important
terms of the securities, including, to the extent applicable:
|
·
|
designation
or classification;
|
|
·
|
aggregate
principal amount or aggregate offering price;
|
|
·
|
maturity
date, if applicable;
|
|
·
|
original
issue discount, if any;
|
|
·
|
rates
and times of payment of interest or dividends, if any;
|
|
·
|
redemption,
conversion, exercise, exchange, or sinking fund terms, if any;
|
|
·
|
restrictive
covenants, if any;
|
|
·
|
voting
or other rights, if any;
|
|
·
|
conversion
or exchange prices or rates, if any, and, if applicable, any provisions for changes to or adjustments in the conversion or exchange
prices or rates and in the securities or other property receivable upon conversion or exchange; and
|
|
·
|
material
or special U.S. federal income tax considerations, if any.
|
The applicable prospectus
supplement and any related free writing prospectus that we may authorize to be provided to you may also add, update or change
any of the information contained in this prospectus or in the documents we have incorporated by reference.
We or selling securityholders
may sell the securities directly to investors or to or through agents, underwriters or dealers. If we or selling securityholders
do offer securities to or through agents or underwriters, we will include in the applicable prospectus supplement:
|
·
|
the
names of those agents or underwriters;
|
|
·
|
applicable
fees, discounts, and commissions to be paid to them;
|
|
·
|
details
regarding over-allotment or other options, if any; and
|
|
·
|
the
net proceeds to us, if any.
|
Common Stock. We may
issue shares of our common stock from time to time. The holders of common stock are entitled to one vote per share on all matters
that are subject to stockholder vote. In this prospectus, we have summarized certain general features of the common stock in the
section entitled “Description of Capital Stock—Common Stock.” We urge you, however, to read the applicable
prospectus supplement (and any related free writing prospectus that we may authorize to be provided to you) related to any common
stock being offered.
Preferred Stock. We may issue
shares of preferred stock from time to time, in one or more series. Under our amended and restated certificate of incorporation, our
board of directors has the authority, without further action by our stockholders (unless such stockholder action is required by applicable
law or the rules of any stock exchange or market on which our securities are then traded), to issue up to 10,000,000 shares of preferred
stock in one or more series and to fix the number, rights, preferences, privileges, and restrictions thereof. These rights, preferences
and privileges could include dividend rights, conversion rights, voting rights, terms of redemption, liquidation preferences, and sinking
fund terms, and the number of shares constituting any series or the designation of such series, any or all of which may be greater than
the rights of common stock. Any convertible preferred stock we may issue will be convertible into our common stock or exchangeable for
our other securities. Conversion may be mandatory or at the holder’s option and would be at prescribed conversion rates.
If we sell any series of preferred stock under this prospectus, we will fix the designations, voting powers, rights, preferences, and privileges of such series of preferred stock, as well as the qualifications, limitations or restrictions thereof, in the certificate of designation relating to that series. We will file as an exhibit to the registration statement of which this prospectus is a part, or will incorporate by reference
from reports that we file with the SEC, the form of any certificate of designation that describes the terms of the series of preferred
stock that we are offering before the issuance of the related series of preferred stock. In this prospectus, we have summarized
certain general features of the preferred stock under the heading “Description of Capital Stock—Preferred Stock.”
We urge you, however, to read the applicable prospectus supplement (and any free writing prospectus that we may authorize to be
provided to you) related to the series of preferred stock being offered, as well as the complete certificate of designation that
contains the terms of the applicable series of preferred stock.
Debt Securities. We
may issue debt securities from time to time, in one or more series, as either senior or subordinated debt or as senior or subordinated
convertible debt. Convertible or exchangeable debt securities will be convertible into or exchangeable for our common stock or
our other securities. Conversion or exchange may be mandatory or optional (at our option or the holders’ option) and would
be at prescribed conversion or exchange prices.
The debt securities will be
issued under an indenture that we will enter into with a national banking association or other eligible party, as trustee. In
this prospectus, we have summarized certain general features of the debt securities in the section entitled “Description
of Debt Securities.” We urge you, however, to read the applicable prospectus supplement (and any related free writing prospectus
that we may authorize to be provided to you) related to the series of debt securities being offered, as well as the complete indenture
and any supplemental indentures that contain the terms of the debt securities. We have filed the form of indenture as an exhibit
to the registration statement of which this prospectus is a part, and supplemental indentures and forms of debt securities containing
the terms of the debt securities being offered will be filed as exhibits to the registration statement of which this prospectus
is a part or will be incorporated by reference from reports that we file with the SEC.
Description of Other Securities.
We will set forth in the applicable prospectus supplement a description of any warrants, purchase contracts, guarantees or
units that may be offered pursuant to this prospectus.
Selling Securityholders
Selling securityholders are
persons or entities that, directly or indirectly, have acquired or will from time to time acquire from us, our securities. Information
about selling securityholders, if any, will be set forth in a prospectus supplement. See the section entitled “Selling Securityholders”
on page 18 of this prospectus.
Use of Proceeds
We intend to use the net proceeds
we receive from the sale of securities by us as set forth in the applicable prospectus supplement. See the section entitled “Use
of Proceeds” on page 7 of this prospectus. Unless the applicable prospectus supplement provides otherwise, we will
not receive any of the proceeds from the sale of our securities by selling securityholders.
New York Stock Exchange
Listing
Our common stock is listed
on the New York Stock Exchange under the symbol “UBER.”
RISK FACTORS
Investing in our securities
involves a high degree of risk. Before deciding whether to invest in our securities, you should consider carefully the risks and
uncertainties described under the heading “Risk Factors” contained in the applicable prospectus supplement and any
related free writing prospectus, and described under the section entitled “Risk Factors” in our most recent Quarterly
Report on Form 10-Q, as well as any amendments thereto reflected in subsequent filings with the SEC, and in our other filings
that are incorporated by reference into this prospectus in their entirety, together with other information in this prospectus,
the documents incorporated by reference and any free writing prospectus that we may authorize for use in connection with a specific
offering. The risks described in these documents are not the only ones we face, but those that we consider to be material. Additional
risks and uncertainties that we are unaware of, or that we currently believe are not material, may also become important factors
that adversely affect our business. Past financial performance may not be a reliable indicator of future performance, and historical
trends should not be used to anticipate results or trends in future periods. If any of these risks actually occurs, our business,
reputation, financial condition, results of operations or cash flow could be seriously harmed. This could cause the trading price
of our common stock to decline, resulting in a loss of all or part of your investment. Please also carefully read the section
entitled “Forward-Looking Statements.”
FORWARD-LOOKING
STATEMENTS
This prospectus and any accompanying
prospectus supplement, as well as the documents incorporated by reference in this prospectus or any accompanying prospectus supplement,
contain “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements relate to future events
or to our future operating or financial performance and involve known and unknown risks, uncertainties and other factors that
may cause our actual results, performance or achievements to be materially different from any future results, performances or
achievements expressed or implied by the forward-looking statements. Forward-looking statements may include, but are not limited
to, statements about:
|
·
|
the
impacts of COVID-19, or other future pandemics on our business, results of operations, financial position, and cash flows;
|
|
·
|
our
ability to successfully compete in highly competitive markets;
|
|
·
|
our
ability to effectively manage our growth and maintain and improve our corporate culture;
|
|
·
|
our
expectations regarding financial performance, including but not limited to revenue, Adjusted Net Revenue, potential profitability
and the timing thereof, ability to generate positive Adjusted EBITDA, expenses, and other results of operations;
|
|
·
|
our
expectations regarding future operating performance, including but not limited to our expectations regarding future Monthly Active
Platform Consumers (“MAPCs”), Trips, Gross Bookings, and Take Rate;
|
|
·
|
our
expectations regarding our competitors’ use of incentives and promotions, our competitors’ ability to raise capital,
and the effects of such incentives and promotions on our growth and results of operations;
|
|
·
|
our
anticipated investments in new products and offerings, and the effect of these investments on our results of operations;
|
|
·
|
our
anticipated capital expenditures and our estimates regarding our capital requirements;
|
|
·
|
our
ability to close and integrate acquisitions into our operations;
|
|
·
|
anticipated
technology trends and developments and our ability to address those trends and developments with our products and offerings;
|
|
·
|
the
size of our addressable markets, market share, category positions, and market trends, including our ability to grow our business
in the six countries we have identified as near-term priorities;
|
|
·
|
the
safety, affordability, and convenience of our platform and our offerings;
|
|
·
|
our
ability to identify, recruit, and retain skilled personnel, including key members of senior management;
|
|
·
|
our
expected growth in the number of platform users, and our ability to promote our brand and attract and retain platform users;
|
|
·
|
our
ability to maintain, protect, and enhance our intellectual property rights;
|
|
·
|
our
ability to introduce new products and offerings and enhance existing products and offerings;
|
|
·
|
our
ability to successfully enter into new geographies, expand our presence in countries in which we are limited by regulatory restrictions,
and manage our international expansion;
|
|
·
|
our
ability to successfully renew licenses to operate our business in certain jurisdictions;
|
|
·
|
the
availability of capital to grow our business;
|
|
·
|
our
ability to meet the requirements of our existing debt and draw on our line of credit;
|
|
·
|
our
ability to prevent disturbance to our information technology systems;
|
|
·
|
our
ability to successfully defend litigation brought against us;
|
|
·
|
our
ability to comply with existing, modified, or new laws and regulations applying to our business;
|
|
·
|
our
ability to implement, maintain, and improve our internal control over financial reporting; and
|
|
·
|
our
anticipated use of the net proceeds from offerings of our securities under this prospectus.
|
In some cases, you can identify
forward-looking statements by terms such as “anticipates,” “believes,” “could,” “estimates,”
“expects,” “may,” “plans,” “potential,” “predicts,” “projects,”
“should,” “would,” “will,” and similar expressions intended to identify forward-looking statements.
These statements reflect our current views with respect to future events, are based on assumptions and are subject to risks and
uncertainties. Given these risks and uncertainties, you should not place undue reliance on these forward-looking statements. We
discuss in greater detail, and incorporate by reference into this prospectus in their entirety, many of these risks and uncertainties
under the heading “Risk Factors” contained in the applicable prospectus supplement, in any free writing prospectus
we may authorize for use in connection with a specific offering, and in our most recent Quarterly Report on Form 10-Q, as well
as any amendments thereto reflected in subsequent filings with the SEC, and in our other filings that are incorporated by
reference into this prospectus. Also, these forward-looking statements represent our estimates and assumptions only as of the
date of the document containing the applicable statement. Unless required by law, we undertake no obligation to update or revise
any forward-looking statements to reflect new information or future events or developments. Thus, you should not assume that our
silence over time means that actual events are bearing out as expressed or implied in such forward-looking statements. You should
read this prospectus, the applicable prospectus supplement, together with the documents we have filed with the SEC that are incorporated
by reference and any free writing prospectus we have authorized for use in connection with a specific offering completely and
with the understanding that our actual future results may be materially different from what we expect. We qualify all of the forward-looking
statements in the foregoing documents by these cautionary statements.
USE OF PROCEEDS
We intend to use the net proceeds
we receive from the sale of securities by us as set forth in the applicable prospectus supplement. Unless otherwise specified
in the applicable prospectus supplement, we will not receive any proceeds from the sale of securities by selling securityholders.
DESCRIPTION
OF CAPITAL STOCK
The following descriptions
of our capital stock, certain provisions of our amended and restated certificate of incorporation and amended and restated bylaws,
and certain provisions of Delaware law are summaries. You should also refer to the amended and restated certificate of incorporation
and the amended and restated bylaws, which are filed as exhibits to the registration statement of which this prospectus is a part.
We refer in this section to our amended and restated certificate of incorporation and amended and restated bylaws as our certificate
of incorporation and bylaws, respectively.
General
Our authorized capital stock
consists of 5,010,000,000 shares, all with a par value of $0.00001 per share, of which:
|
·
|
5.0 billion
shares are designated as common stock; and
|
|
·
|
10.0 million
shares are designated as preferred stock.
|
Our shares of common stock
are not redeemable and have no preemptive rights. Our board of directors is authorized, without stockholder approval except as
required by the listing standards of the New York Stock Exchange, to issue additional shares of our capital stock.
Common Stock
Holders of our common stock
are entitled to one vote per share on any matter submitted to our stockholders. Our amended and restated certificate of incorporation
does not provide for cumulative voting for the election of directors. Subject to preferences that may be applicable to any outstanding
preferred stock, the holders of common stock are entitled to receive ratably such dividends, if any, as may be declared from time
to time by our board of directors, out of funds legally available therefor. In the event of liquidation, dissolution, or winding
up of the company, the holders of common stock are entitled to share ratably in all assets remaining after payment of liabilities,
subject to prior distribution rights of preferred stock, if any, then outstanding. Our common stock is not entitled to preemptive
rights, and is not subject to conversion, redemption, or sinking fund provisions.
Preferred Stock
Pursuant to our amended and
restated certificate of incorporation, our board of directors may, without further action by our stockholders, fix the rights,
preferences, privileges, and restrictions of up to an aggregate of 10.0 million shares of our preferred stock in one or more
series and authorize their issuance. These rights, preferences, and privileges could include dividend rights, conversion rights,
voting rights, terms of redemption, liquidation preferences, and the number of shares constituting any series or the designation
of such series, any or all of which may be greater than the rights of our common stock. Any issuance of our preferred stock could
adversely affect the voting power of holders of our common stock, and the likelihood that such holders would receive dividend
payments and payments on liquidation. In addition, the issuance of preferred stock could have the effect of delaying, deferring
or preventing a change of control or other corporate action. As of June 30, 2020, no shares of preferred stock were outstanding.
The prospectus supplement relating to a particular class or series of preferred stock offered will describe the specific terms
thereof, including, where applicable:
|
·
|
the
title, designation, number of shares and stated value of the preferred stock;
|
|
·
|
the
price at which the preferred stock will be issued;
|
|
·
|
the
dividend rates, if any (or method of calculation), whether that rate is fixed or variable or both, and the dates on which dividends
will be payable, whether those dividends will be cumulative or noncumulative and, if cumulative, the dates from which dividends
will begin to cumulate;
|
|
·
|
the
dates on which the preferred stock will be subject to redemption and the applicable redemption prices;
|
|
·
|
any
redemption or sinking fund provisions;
|
|
·
|
the
convertibility or exchangeability of the preferred stock;
|
|
·
|
if
other than U.S. dollars, the currency or currencies (including composite currencies) in which the preferred stock is denominated
and/or in which payments will or may be payable;
|
|
·
|
the
method by which amounts in respect of the preferred stock may be calculated and any commodities, currencies or indices, or the
value, rate or price relevant to that calculation;
|
|
·
|
the
place where dividends and other payments on the preferred stock are payable and the identity of the transfer agent, registrar
and dividend disbursement agent for the preferred stock;
|
|
·
|
any
listing of the preferred stock on any securities exchange; and
|
|
·
|
any
additional dividend, liquidation, redemption, preemption, sinking fund, voting and other rights, preferences, privileges, limitations
and restrictions.
|
Anti-Takeover Provisions
Amended and Restated
Certificate of Incorporation and Amended and Restated Bylaws
Because our stockholders do
not have cumulative voting rights, stockholders holding a majority of the voting power of our shares of common stock will be able
to elect all of our directors. Our amended and restated certificate of incorporation and amended and restated bylaws provide for
stockholder actions only at a duly called meeting of stockholders. A special meeting of stockholders may be called by a majority
of our board of directors, the chair of our board of directors, or our Chief Executive Officer. Our amended and restated bylaws
establish an advance notice procedure for stockholder proposals to be brought before an annual meeting of our stockholders, including
proposed nominations of persons for election to our board of directors. Our board of directors has the right to elect directors
to fill vacancies created by the expansion of our board of directors or the resignation, death, or removal of a director, which
prevents stockholders from being able to fill vacancies on our board of directors.
Anti-Takeover
Statute
We are subject to, and have
not opted out of, Section 203 of the Delaware General Corporation Law, which prohibits a Delaware corporation from engaging
in any business combination with any interested stockholder for a period of three years after the date that such stockholder became
an interested stockholder, with the following exceptions:
|
·
|
before
such date, the board of directors of the corporation approved either the business combination or the transaction that resulted
in the stockholder becoming an interested stockholder;
|
|
·
|
upon
completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder
owned at least 85% of the voting stock of the corporation outstanding at the time the transaction began, excluding for purposes
of determining the voting stock outstanding (but not the outstanding voting stock owned by the interested stockholder) those shares
owned (i) by persons who are directors and also officers and (ii) employee stock plans in which employee participants
do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange
offer; or
|
|
·
|
on
or after such date, the business combination is approved by the board of directors and authorized at an annual or special meeting
of the stockholders by the affirmative vote of at least 66 and 2/3 percent of the outstanding voting stock that is not
owned by the interested stockholder.
|
In general, Section 203 defines
a “business combination” to include the following:
|
·
|
any
merger or consolidation involving the corporation and the interested stockholder;
|
|
·
|
any
sale, transfer, pledge or other disposition of 10 percent or more of the assets of the corporation involving the interested
stockholder;
|
|
·
|
subject
to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation
to the interested stockholder;
|
|
·
|
any
transaction involving the corporation that has the effect of increasing the proportionate share of the stock or any class or series
of the corporation beneficially owned by the interested stockholder; or
|
|
·
|
the
receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits by
or through the corporation.
|
In general, Section 203
defines an “interested stockholder” as an entity or person who, together with the person’s affiliates and associates,
beneficially owns, or within three years prior to the time of determination of interested stockholder status did own, 15% or more
of the outstanding voting stock of the corporation.
A Delaware corporation may
“opt out” of these provisions with an express provision in its original certificate of incorporation or an express
provision in its amended and restated certificate of incorporation or amended and restated bylaws resulting from a stockholders’
amendment approved by at least a majority of the outstanding voting shares. We have not opted out of these provisions. As a result,
mergers or other takeover or change in control attempts of us may be discouraged or prevented.
Choice of Forum
Our amended and restated certificate
of incorporation provides that the Court of Chancery of the State of Delaware will be the exclusive forum for the following types
of actions or proceedings under Delaware statutory or common law: (i) any derivative action or proceeding brought on our
behalf; (ii) any action asserting a breach of fiduciary duty; (iii) any action asserting a claim against us or our directors,
officers, or employees arising under the Delaware General Corporation Law, our amended and restated certificate of incorporation,
or our amended and restated bylaws; (iv) any action regarding our amended and restated certificate of incorporation or our
amended and restated bylaws; (v) any action as to which the Delaware General Corporation Law confers jurisdiction to the
Court of Chancery of the State of Delaware; or (vi) any action asserting a claim against us that is governed by the internal
affairs doctrine. The provisions would not apply to suits brought to enforce a duty or liability created by the Exchange Act or
any other claim for which the U.S. federal courts have exclusive jurisdiction. Our amended and restated certificate of incorporation
further provides that the federal district courts of the United States of America will be the exclusive forum for resolving any
complaint asserting a cause of action arising under the Securities Act.
Transfer Agent and Registrar
The transfer agent and registrar
for our common stock is Computershare Trust Company, N.A. The transfer agent’s address is 250 Royall Street, Canton,
Massachusetts 02021.
Listing on the New York
Stock Exchange
Our common stock is listed
on the New York Stock Exchange under the trading symbol “UBER.”
DESCRIPTION
OF DEBT SECURITIES
We may issue debt securities
from time to time, in one or more series, as either senior or subordinated debt or as senior or subordinated convertible debt.
While the terms we have summarized below will apply generally to any debt securities that we may offer under this prospectus,
we will describe the particular terms of any debt securities that we may offer in more detail in the applicable prospectus supplement.
The terms of any debt securities offered under a prospectus supplement may differ from the terms described below. Unless the context
requires otherwise, whenever we refer to the indenture, we also are referring to any supplemental indentures that specify the
terms of a particular series of debt securities.
We will issue the debt securities
under the indenture that we will enter into with the trustee named in the indenture. The indenture will be qualified under the
Trust Indenture Act of 1939, as amended (the “Trust Indenture Act”). We have filed the form of indenture as an exhibit
to the registration statement of which this prospectus is a part, and supplemental indentures and forms of debt securities containing
the terms of the debt securities being offered will be filed as exhibits to the registration statement of which this prospectus
is a part or will be incorporated by reference from reports that we file with the SEC.
The following summary of material
provisions of the debt securities and the indenture is subject to, and qualified in its entirety by reference to, all of the provisions
of the indenture applicable to a particular series of debt securities. We urge you to read the applicable prospectus supplements
and any related free writing prospectuses related to the debt securities that we may offer under this prospectus, as well as the
complete indenture that contains the terms of the debt securities.
General
The indenture does not limit
the amount of debt securities that we may issue. It provides that we may issue debt securities up to the principal amount that
we may authorize and may be in any currency or currency unit that we may designate. Except for the limitations on consolidation,
merger and sale of all or substantially all of our assets contained in the indenture, the terms of the indenture do not contain
any covenants or other provisions designed to give holders of any debt securities protection against changes in our operations,
financial condition or transactions involving us.
We may issue the debt securities
issued under the indenture as “discount securities,” which means they may be sold at a discount below their stated
principal amount. These debt securities, as well as other debt securities that are not issued at a discount, may be issued with
“original issue discount” (“OID”), for U.S. federal income tax purposes because of interest payment and
other characteristics or terms of the debt securities. Material U.S. federal income tax considerations applicable to debt securities
issued with OID will be described in more detail in any applicable prospectus supplement.
We will describe in the applicable
prospectus supplement the terms of the series of debt securities being offered, including:
|
·
|
the
title of the series of debt securities;
|
|
·
|
any
limit upon the aggregate principal amount that may be issued;
|
|
·
|
the
maturity date or dates;
|
|
·
|
the
form of the debt securities of the series;
|
|
·
|
the
applicability of any guarantees;
|
|
·
|
whether
or not the debt securities will be secured or unsecured, and the terms of any secured debt;
|
|
·
|
whether
the debt securities rank as senior debt, senior subordinated debt, subordinated debt, or any combination thereof, and the terms
of any subordination;
|
|
·
|
if
the price (expressed as a percentage of the aggregate principal amount thereof) at which such debt securities will be issued is
a price other than the principal amount thereof, the portion of the principal amount thereof payable upon declaration of acceleration
of the maturity thereof, or if applicable, the portion of the principal amount of such debt securities that is convertible into
another security or the method by which any such portion shall be determined;
|
|
·
|
the
interest rate or rates, which may be fixed or variable, or the method for determining the rate and the date interest will begin
to accrue, the dates interest will be payable and the regular record dates for interest payment dates or the method for determining
such dates;
|
|
·
|
our
right, if any, to defer payment of interest and the maximum length of any such deferral period;
|
|
·
|
if
applicable, the date or dates after which, or the period or periods during which, and the price or prices at which, we may, at
our option, redeem the series of debt securities pursuant to any optional or provisional redemption provisions and the terms of
those redemption provisions;
|
|
·
|
the
date or dates, if any, on which, and the price or prices at which we are obligated, pursuant to any mandatory sinking fund or
analogous fund provisions or otherwise, to redeem, or at the holder’s option to purchase, the series of debt securities
and the currency or currency unit in which the debt securities are payable;
|
|
·
|
the
denominations in which we will issue the series of debt securities, if other than denominations of $1,000 and any integral multiple
thereof;
|
|
·
|
any
and all terms, if applicable, relating to any auction or remarketing of the debt securities of that series and any security for
our obligations with respect to such debt securities and any other terms which may be advisable in connection with the marketing
of debt securities of that series;
|
|
·
|
whether
the debt securities of the series shall be issued in whole or in part in the form of a global security or securities; the terms
and conditions, if any, upon which such global security or securities may be exchanged in whole or in part for other individual
securities; and the depositary for such global security or securities;
|
|
·
|
if
applicable, the provisions relating to conversion or exchange of any debt securities of the series and the terms and conditions
upon which such debt securities will be so convertible or exchangeable, including the conversion or exchange price, as applicable,
or how it will be calculated and may be adjusted, any mandatory or optional (at our option or the holders’ option) conversion
or exchange features, the applicable conversion or exchange period and the manner of settlement for any conversion or exchange;
|
|
·
|
if
other than the full principal amount thereof, the portion of the principal amount of debt securities of the series which shall
be payable upon declaration of acceleration of the maturity thereof;
|
|
·
|
additions
to or changes in the covenants applicable to the particular debt securities being issued, including, among others, the consolidation,
merger, or sale covenant;
|
|
·
|
additions
to or changes in the events of default with respect to the securities and any change in the right of the trustee or the holders
to declare the principal, premium, if any, and interest, if any, with respect to such securities to be due and payable;
|
|
·
|
additions
to or changes in or deletions of the provisions relating to covenant defeasance and legal defeasance;
|
|
·
|
additions
to or changes in the provisions relating to satisfaction and discharge of the indenture;
|
|
·
|
additions
to or changes in the provisions relating to the modification of the indenture both with and without the consent of holders of
debt securities issued under the indenture;
|
|
·
|
the
currency of payment of debt securities if other than U.S. dollars and the manner of determining the equivalent amount in U.S.
dollars;
|
|
·
|
whether
interest will be payable in cash or additional debt securities at our or the holders’ option and the terms and conditions
upon which the election may be made;
|
|
·
|
the
terms and conditions, if any, upon which we will pay amounts in addition to the stated interest, premium, if any and principal
amounts of the debt securities of the series to any holder that is not a “United States person” for federal tax purposes;
|
|
·
|
any
restrictions on transfer, sale or assignment of the debt securities of the series; and
|
|
·
|
any
other specific terms, preferences, rights or limitations of, or restrictions on, the debt securities, any other additions or changes
in the provisions of the indenture, and any terms that may be required by us or advisable under applicable laws or regulations.
|
Conversion or Exchange
Rights
We will set forth in the applicable
prospectus supplement the terms on which a series of debt securities may be convertible into or exchangeable for our common stock
or our other securities. We will include provisions as to settlement upon conversion or exchange and whether conversion or exchange
is mandatory, at the option of the holder or at our option. We may include provisions pursuant to which the number of shares of
our common stock or our other securities that the holders of the series of debt securities receive would be subject to adjustment.
Consolidation, Merger,
or Sale
Unless we provide otherwise
in the prospectus supplement applicable to a particular series of debt securities, the indenture will not contain any covenant
that restricts our ability to merge or consolidate, or sell, convey, transfer or otherwise dispose of our assets as an entirety
or substantially as an entirety. However, any successor to or acquirer of such assets (other than a subsidiary of ours) must assume
all of our obligations under the indenture or the debt securities, as appropriate.
Events of Default Under
the Indenture
Unless we provide otherwise
in the prospectus supplement applicable to a particular series of debt securities, the following are events of default under the
indenture with respect to any series of debt securities that we may issue:
|
·
|
if
we fail to pay any installment of interest on any series of debt securities, as and when the same shall become due and payable,
and such default continues for a period of 90 days; provided, however, that a valid extension of an interest payment period by
us in accordance with the terms of any indenture supplemental thereto shall not constitute a default in the payment of interest
for this purpose;
|
|
·
|
if
we fail to pay the principal of, or premium, if any, on any series of debt securities as and when the same shall become due and
payable whether at maturity, upon redemption, by declaration or otherwise, or in any payment required by any sinking or analogous
fund established with respect to such series; provided, however, that a valid extension of the maturity of such debt securities
in accordance with the terms of any indenture supplemental thereto shall not constitute a default in the payment of principal
or premium, if any;
|
|
·
|
if
we fail to observe or perform any other covenant or agreement contained in the debt securities or the indenture, other than a
covenant specifically relating to another series of debt securities, and our failure continues for 90 days after we receive
written notice of such failure, requiring the same to be remedied and stating that such is a notice of default thereunder, from
the trustee or holders of at least 25% in aggregate principal amount of the outstanding debt securities of the applicable series;
and
|
|
·
|
if
specified events of bankruptcy, insolvency, or reorganization occur.
|
If an event of default
with respect to debt securities of any series occurs and is continuing, other than an event of default specified in the last
bullet point above, the trustee or the holders of at least 25% in aggregate principal amount of the outstanding debt
securities of that series, by notice to us in writing, and to the trustee if notice is given by such holders, may declare the
unpaid principal of, premium, if any, and accrued interest, if any, due and payable immediately. If an event of default
specified in the last bullet point above occurs with respect to us, the principal amount of and accrued interest, if any, of
each issue of debt securities then outstanding shall be due and payable without any notice or other action on the part of the
trustee or any holder.
The holders of a majority
in principal amount of the outstanding debt securities of an affected series may waive any default or event of default with respect
to the series and its consequences, except defaults or events of default regarding payment of principal, premium, if any, or interest,
unless we have cured the default or event of default in accordance with the indenture. Any waiver shall cure the default or event
of default.
Subject to the terms of the
indenture, if an event of default under an indenture shall occur and be continuing, the trustee will be under no obligation to
exercise any of its rights or powers under such indenture at the request or direction of any of the holders of the applicable
series of debt securities, unless such holders have offered the trustee reasonable indemnity. The holders of a majority in principal
amount of the outstanding debt securities of any series will have the right to direct the time, method and place of conducting
any proceeding for any remedy available to the trustee, or exercising any trust or power conferred on the trustee, with respect
to the debt securities of that series, provided that:
|
·
|
the
direction so given by the holder is not in conflict with any law or the applicable indenture; and
|
|
·
|
subject
to its duties under the Trust Indenture Act, the trustee need not take any action that might involve it in personal liability
or might be unduly prejudicial to the holders not involved in the proceeding.
|
A holder of the debt securities
of any series will have the right to institute a proceeding under the indenture or to appoint a receiver or trustee, or to seek
other remedies only if:
|
·
|
the
holder has given written notice to the trustee of a continuing event of default with respect to that series;
|
|
·
|
the
holders of at least 25% in aggregate principal amount of the outstanding debt securities of that series have made written request;
|
|
·
|
such
holders have offered to the trustee indemnity satisfactory to it against the costs, expenses and liabilities to be incurred by
the trustee in compliance with the request; and
|
|
·
|
the
trustee does not institute the proceeding, and does not receive from the holders of a majority in aggregate principal amount of
the outstanding debt securities of that series other conflicting directions within 90 days after the notice, request and
offer.
|
These limitations do not apply
to a suit instituted by a holder of debt securities if we default in the payment of the principal, premium, if any, or interest
on, the debt securities.
We will periodically file
statements with the trustee regarding our compliance with specified covenants in the indenture.
Modification of Indenture;
Waiver
We and the trustee may change
an indenture without the consent of any holders with respect to specific matters:
|
·
|
to
cure any ambiguity, defect or inconsistency in the indenture or in the debt securities of any series;
|
|
·
|
to
comply with the provisions described above in the subsection entitled—Consolidation, Merger, or Sale;”
|
|
·
|
to
provide for uncertificated debt securities in addition to or in place of certificated debt securities;
|
|
·
|
to
add to our covenants, restrictions, conditions or provisions such new covenants, restrictions, conditions or provisions for the
benefit of the holders of all or any series of debt securities, to make the occurrence, or the occurrence and the continuance,
of a default in any such additional covenants, restrictions, conditions or provisions an event of default or to surrender any
right or power conferred upon us in the indenture;
|
|
·
|
to
add to, delete from or revise the conditions, limitations, and restrictions on the authorized amount, terms, or purposes of issue,
authentication, and delivery of debt securities, as set forth in the indenture;
|
|
·
|
to
make any change that does not adversely affect the interests of any holder of debt securities of any series in any material respect;
|
|
·
|
to
provide for the issuance of and establish the form and terms and conditions of the debt securities of any series as provided above
in the subsection entitled—General” to establish the form of any certifications required to be furnished pursuant
to the terms of the indenture or any series of debt securities, or to add to the rights of the holders of any series of debt securities;
|
|
·
|
to
evidence and provide for the acceptance of appointment under any indenture by a successor trustee; or
|
|
·
|
to
comply with any requirements of the SEC in connection with the qualification of any indenture under the Trust Indenture Act.
|
In addition, under the indenture,
the rights of holders of a series of debt securities may be changed by us and the trustee with the written consent of the holders
of at least a majority in aggregate principal amount of the outstanding debt securities of each series that is affected. However,
unless we provide otherwise in the prospectus supplement applicable to a particular series of debt securities, we and the trustee
may make the following changes only with the consent of each holder of any outstanding debt securities affected:
|
·
|
extending
the fixed maturity of any debt securities of any series;
|
|
·
|
reducing
the principal amount, reducing the rate of or extending the time of payment of interest, or reducing any premium payable upon
the redemption of any series of any debt securities; or
|
|
·
|
reducing
the percentage of debt securities, the holders of which are required to consent to any amendment, supplement, modification or
waiver.
|
Discharge
Each indenture provides that
we can elect to be discharged from our obligations with respect to one or more series of debt securities, except for specified
obligations, including obligations to:
|
·
|
register
the transfer or exchange of debt securities of the series;
|
|
·
|
replace
stolen, lost or mutilated debt securities of the series;
|
|
·
|
pay
principal of and premium and interest on any debt securities of the series;
|
|
·
|
maintain
paying agencies;
|
|
·
|
hold
monies for payment in trust;
|
|
·
|
recover
excess money held by the trustee;
|
|
·
|
compensate
and indemnify the trustee; and
|
|
·
|
appoint
any successor trustee.
|
In order to exercise our rights to
be discharged, we must deposit with the trustee money or government obligations sufficient to pay all the principal of, any premium,
if any, and interest on, the debt securities of the series on the dates payments are due.
Form, Exchange, and Transfer
We will issue the debt securities
of each series only in fully registered form without coupons and, unless we provide otherwise in the applicable prospectus supplement,
in denominations of $1,000 and any integral multiple thereof. The indenture provides that we may issue debt securities of a series
in temporary or permanent global form and as book-entry securities that will be deposited with, or on behalf of, The Depository
Trust Company (“DTC”), or another depositary named by us and identified in the applicable prospectus supplement with
respect to that series. To the extent the debt securities of a series are issued in global form and as book-entry, a description
of terms relating to any book-entry securities will be set forth in the applicable prospectus supplement.
At the option of the holder,
subject to the terms of the indenture and the limitations applicable to global securities described in the applicable prospectus
supplement, the holder of the debt securities of any series can exchange the debt securities for other debt securities of the
same series, in any authorized denomination and of like tenor and aggregate principal amount.
Subject to the terms of the
indenture and the limitations applicable to global securities set forth in the applicable prospectus supplement, holders of the
debt securities may present the debt securities for exchange or for registration of transfer, duly endorsed or with the form of
transfer endorsed thereon duly executed if so required by us or the security registrar, at the office of the security registrar
or at the office of any transfer agent designated by us for this purpose. Unless otherwise provided in the debt securities that
the holder presents for transfer or exchange, we will impose no service charge for any registration of transfer or exchange, but
we may require payment of any taxes or other governmental charges.
We will name in the applicable
prospectus supplement the security registrar, and any transfer agent in addition to the security registrar, that we initially
designate for any debt securities. We may at any time designate additional transfer agents or rescind the designation of any transfer
agent or approve a change in the office through which any transfer agent acts, except that we will be required to maintain a transfer
agent in each place of payment for the debt securities of each series.
If we elect to redeem the
debt securities of any series, we will not be required to:
|
·
|
issue,
register the transfer of, or exchange any debt securities of that series during a period beginning at the opening of business
15 days before the day of mailing of a notice of redemption of any debt securities that may be selected for redemption and
ending at the close of business on the day of the mailing; or
|
|
·
|
register
the transfer of or exchange any debt securities so selected for redemption, in whole or in part, except the unredeemed portion
of any debt securities we are redeeming in part.
|
Information Concerning
the Trustee
The trustee, other than during
the occurrence and continuance of an event of default under an indenture, undertakes to perform only those duties as are specifically
set forth in the applicable indenture. Upon an event of default under an indenture, the trustee must use the same degree of care
as a prudent person would exercise or use in the conduct of his or her own affairs. Subject to this provision, the trustee is
under no obligation to exercise any of the powers given it by the indenture at the request of any holder of debt securities unless
it is offered reasonable security and indemnity against the costs, expenses and liabilities that it might incur.
Payment and Paying Agents
Unless we otherwise indicate
in the applicable prospectus supplement, we will make payment of the interest on any debt securities on any interest payment date
to the person in whose name the debt securities, or one or more predecessor securities, are registered at the close of business
on the regular record date for the interest.
We will pay principal of and
any premium and interest on the debt securities of a particular series at the office of the paying agents designated by us, except
that unless we otherwise indicate in the applicable prospectus supplement, we will make interest payments by check that we will
mail to the holder or by wire transfer to certain holders. Unless we otherwise indicate in the applicable prospectus supplement,
we will designate the corporate trust office of the trustee as our sole paying agent for payments with respect to debt securities
of each series. We will name in the applicable prospectus supplement any other paying agents that we initially designate for the
debt securities of a particular series. We will maintain a paying agent in each place of payment for the debt securities of a
particular series.
All money we pay to a paying
agent or the trustee for the payment of the principal of or any premium or interest on any debt securities that remains unclaimed
at the end of two years after such principal, premium or interest has become due and payable will be repaid to us, and the holder
of the debt security thereafter may look only to us for payment thereof.
Governing Law
The indenture and the debt
securities will be governed by and construed in accordance with the internal laws of the State of New York, except to the extent
that the Trust Indenture Act is applicable.
SELLING SECURITYHOLDERS
Information about selling
securityholders, where applicable, will be set forth in a prospectus supplement, in a post-effective amendment to this registration
statement, or in filings we make with the SEC under the Exchange Act that are incorporated by reference.
PLAN OF DISTRIBUTION
We or selling securityholders
may sell the securities from time to time pursuant to underwritten public offerings, “at-the-market” offerings, negotiated
transactions, block trades, or a combination of these methods, or through any other methods described in a prospectus supplement.
We or selling securityholders may sell the securities to or through one or more underwriters or dealers (acting as principal or
agent), through agents, directly to one or more purchasers, or as otherwise described in a prospectus supplement. We or selling
securityholders may distribute securities from time to time in one or more transactions:
|
·
|
at
a fixed price or prices, which may be changed;
|
|
·
|
at
market prices prevailing at the time of sale;
|
|
·
|
at
prices related to such prevailing market prices; or
|
A prospectus supplement or
supplements (and any related free writing prospectus that we may authorize to be provided to you) will describe the terms of the
offering of the securities, including, to the extent applicable:
|
·
|
the
name or names of the underwriters, dealers, or agents, if any;
|
|
·
|
the
name or names of the selling securityholders, if any;
|
|
·
|
the
purchase price of the securities or other consideration therefor, and the proceeds, if any, we will receive from the sale;
|
|
·
|
any
over-allotment or other options under which underwriters may purchase additional securities from us or any selling securityholders;
|
|
·
|
any
agency fees or underwriting discounts and other items constituting agents’ or underwriters’ compensation;
|
|
·
|
any
public offering price;
|
|
·
|
any
discounts or concessions allowed or reallowed or paid to dealers; and
|
|
·
|
any
securities exchange or market on which the securities may be listed.
|
Only underwriters named in
the prospectus supplement will be underwriters of the securities offered by the prospectus supplement. Dealers and agents participating
in the distribution of the securities may be deemed to be underwriters, and compensation received by them on resale of the securities
may be deemed to be underwriting discounts. If such dealers or agents were deemed to be underwriters, they may be subject to statutory
liabilities under the Securities Act.
If underwriters are used in
the sale, they will acquire the securities for their own account and may resell the securities from time to time in one or more
transactions at a fixed public offering price or at varying prices determined at the time of sale. The obligations of the underwriters
to purchase the securities will be subject to the conditions set forth in the applicable underwriting agreement. We or selling
securityholders may offer the securities to the public through underwriting syndicates represented by managing underwriters or
by underwriters without a syndicate. Subject to certain conditions, the underwriters will be obligated to purchase all of the
securities offered by the prospectus supplement, other than securities covered by any over-allotment option. If a dealer is used
in the sale of securities, we, a selling stockholder, or an underwriter will sell the securities to the dealer, as principal.
The dealer may then resell the securities to the public at varying prices to be determined by the dealer at the time of resale.
To the extent required, we will set forth in the prospectus supplement the name of the dealer and the terms of the transaction.
Any public offering price and any discounts or concessions allowed or reallowed or paid to dealers may change from time to time.
We or selling securityholders may
use underwriters, dealers, or agents with whom we have a material relationship. We will describe in the prospectus supplement,
naming the underwriter, dealer, or agent, the nature of any such relationship.
We or selling securityholders
may sell securities directly or through agents we designate from time to time. We will name any agent involved in the offering
and sale of securities and we will describe any commissions payable to the agent in the prospectus supplement. Unless the prospectus
supplement states otherwise, the agent will act on a best-efforts basis for the period of its appointment.
We may provide agents, underwriters
and dealers with indemnification against civil liabilities, including liabilities under the Securities Act, or contribution with
respect to payments that the agents, underwriters or dealers may make with respect to these liabilities. Agents, underwriters
and dealers, or their affiliates, may engage in transactions with, or perform services for, us in the ordinary course of business.
Selling securityholders may
be deemed to be underwriters under the Securities Act in connection with the securities they resell and any profits on the sales
may be deemed to be underwriting discounts and commissions under the Securities Act.
All securities we may offer,
other than common stock, will be new issues of securities with no established trading market. Any underwriters may make a market
in these securities, but will not be obligated to do so and may discontinue any market making at any time without notice. We cannot
guarantee the liquidity of the trading markets for any securities.
Any underwriter may engage
in over-allotment, stabilizing transactions, short-covering transactions and penalty bids in accordance with Regulation M under
the Exchange Act. Over-allotment involves sales in excess of the offering size, which create a short position. Stabilizing transactions
permit bids to purchase the underlying security so long as the stabilizing bids do not exceed a specified maximum price. Syndicate-covering
or other short-covering transactions involve purchases of the securities, either through exercise of the over-allotment option
or in the open market after the distribution is completed, to cover short positions. Penalty bids permit the underwriters to reclaim
a selling concession from a dealer when the securities originally sold by the dealer are purchased in a stabilizing or covering
transaction to cover short positions. Those activities may cause the price of the securities to be higher than it would otherwise
be. If commenced, the underwriters may discontinue any of the activities at any time.
Any underwriters that are
qualified market makers on the New York Stock Exchange may engage in passive market making transactions in the common stock on
the New York Stock Exchange in accordance with Regulation M under the Exchange Act, during the business day prior to the pricing
of the offering, before the commencement of offers or sales of the common stock. Passive market makers must comply with applicable
volume and price limitations and must be identified as passive market makers. In general, a passive market maker must display
its bid at a price not in excess of the highest independent bid for such security; if all independent bids are lowered below the
passive market maker’s bid, however, the passive market maker’s bid must then be lowered when certain purchase limits
are exceeded. Passive market making may stabilize the market price of the securities at a level above that which might otherwise
prevail in the open market and, if commenced, may be discontinued at any time.
In compliance with guidelines
of the Financial Industry Regulatory Authority (“FINRA”) the maximum consideration or discount to be received by any
FINRA member or independent broker dealer may not exceed 8% of the aggregate amount of the securities offered pursuant to this
prospectus and the applicable prospectus supplement.
LEGAL MATTERS
Unless otherwise indicated
in the applicable prospectus supplement, the validity of the securities offered by this prospectus, and any supplement thereto,
will be passed upon for us by Cooley LLP, San Francisco, California.
EXPERTS
The financial statements incorporated
in this Prospectus by reference to the Annual Report on Form 10-K for the year ended December 31 2019 have been so incorporated
in reliance on the report of PricewaterhouseCoopers LLP, an independent registered public accounting firm, given on the authority
of said firm as experts in auditing and accounting.
WHERE
YOU CAN FIND MORE INFORMATION
This prospectus is part of
a registration statement we filed with the SEC. This prospectus does not contain all of the information set forth in the registration
statement and the exhibits to the registration statement. For further information with respect to us and the securities we are
offering under this prospectus, we refer you to the registration statement and the exhibits and schedules filed as a part of the
registration statement. You should rely only on the information contained in this prospectus or incorporated by reference. We
have not authorized anyone else to provide you with different information. We are not making an offer of these securities in any
state where the offer is not permitted. You should not assume that the information in this prospectus is accurate as of any date
other than the date on the front page of this prospectus, regardless of the time of delivery of this prospectus or any sale of
the securities offered by this prospectus.
We file annual, quarterly
and current reports, proxy and information statements and other information with the SEC. The SEC maintains a website that contains
reports, proxy and information statements and other information regarding issuers that file electronically with the SEC, including
Uber. The address of the SEC website is www.sec.gov.
We maintain a website at www.uber.com.
Information contained in or accessible through our website does not constitute a part of this prospectus.
INCORPORATION
OF CERTAIN INFORMATION BY REFERENCE
The SEC allows us to “incorporate
by reference” information from other documents that we file with it, which means that we can disclose important information
to you by referring you to those documents. The information incorporated by reference is considered to be part of this prospectus.
Information in this prospectus supersedes information incorporated by reference that we filed with the SEC prior to the date of
this prospectus, while information that we file later with the SEC will automatically update and supersede the information in
this prospectus. We incorporate by reference into this prospectus and the registration statement of which this prospectus is a
part the information or documents listed below that we have filed with the SEC (Commission File No. 001-38902):
|
·
|
our
Annual Report on Form 10-K for the year ended December 31, 2019, filed with the SEC on March 2, 2020;
|
|
·
|
our
Quarterly Report on Form 10-Q for the quarter ended and March 31, 2020, filed with the SEC on May 8, 2020;
|
|
·
|
our
Current Reports on Form 8-K, filed with the SEC on January 6, 2020, January 21, 2020, February 19, 2020, March 23, 2020, April 28, 2020, May 6, 2020, May 13, 2020, May 15, 2020, May 18, 2020, May 22, 2020,
July 2, 2020, July 6, 2020, and July 17, 2020, to the extent the information in such reports is filed and not
furnished;
|
|
·
|
the
information specifically incorporated by reference into our Annual Report on Form 10-K for the year ended December 31, 2019
from our definitive proxy statement relating to our 2020 annual meeting of stockholders, filed with the SEC on April 27,
2020; and
|
|
·
|
the
description of our common stock contained in our Registration Statement on Form 8-A, filed with the SEC on May 7, 2019, including
any amendments or reports filed for the purposes of updating this description.
|
We also incorporate by reference
any future filings (other than current reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed
on such form that are related to such items unless such Form 8-K expressly provides to the contrary) made with the SEC pursuant
to Sections 13(a), 13(c), 14, or 15(d) of the Exchange Act until we file a post-effective amendment that indicates the termination
of the offering of the securities made by this prospectus and will become a part of this prospectus from the date that such documents
are filed with the SEC. Information in such future filings updates and supplements the information provided in this prospectus.
Any statements in any such future filings will automatically be deemed to modify and supersede any information in any document
we previously filed with the SEC that is incorporated or deemed to be incorporated herein by reference to the extent that statements
in the later filed document modify or replace such earlier statements.
We will furnish without charge
to each person, including any beneficial owner, to whom a prospectus is delivered, upon written or oral request, a copy of any
or all of the documents incorporated by reference, including exhibits to these documents. Any such request may be made by writing
or telephoning us at the following address or phone number:
Uber Technologies,
Inc.
1455 Market Street, 4th Floor
San Francisco, California
94103
(415) 612-8582
Attention: Secretary
Uber Technologies (NYSE:UBER)
Historical Stock Chart
From Aug 2024 to Sep 2024
Uber Technologies (NYSE:UBER)
Historical Stock Chart
From Sep 2023 to Sep 2024